Disease Studies

PrecisionLife identified as leaders in fight against COVID-19 by Barclays Private Bank


Oxford, UK – PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Private Bank.  In an article published in September 2020, our unique technology platforms were highlighted, following our discovery of 68 genes that could be responsible for some of the more severe symptoms experienced by some people infected by the SARS-CoV-2 virus.

To read the article in full, visit https://privatebank.barclays.com/news-and-insights/2020/september/pandemic-precision-medicine/?cid=mm03soc_sc01ca07cr17co121te01ts18&linkId=100000016578707#

More News & Media

View All News & Media

UK BioIndustry Association launches first TechBio company report

OXFORD, UK: PrecisionLife featured as a case study of how a data-driven techbio company is transforming drug discovery and…

Read more

Best Chronic Disease Biology Company 2021 awarded to PrecisionLife

OXFORD, UK The International Life Sciences Awards has named PrecisionLife as the Best Chronic Disease Biology R&D Company 2021.

Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.

Contact us

If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.


Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ


1 Broadway Fl 14
MA 02142-1187


Agern Allé 3


Chmielna 73m
00-801 Warszawa